Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Axonics Modulation Technologies Inc

AXNX
Current price
67.13 USD -0.04 USD (-0.06%)
Last closed 67.22 USD
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 3 429 463 552 USD
Yield for 12 month +39.48 %
1Y
3Y
5Y
10Y
15Y
AXNX
21.11.2021 - 28.11.2021

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California. Address: 26 Technology Drive, Irvine, CA, United States, 92618

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

71.73 USD

P/E ratio

Dividend Yield

Current Year

+366 379 000 USD

Last Year

+273 702 000 USD

Current Quarter

+91 409 000 USD

Last Quarter

+109 735 000 USD

Current Year

+265 490 000 USD

Last Year

+197 665 000 USD

Current Quarter

+69 253 000 USD

Last Quarter

+80 499 000 USD

Key Figures AXNX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 5 392 000 USD
Operating Margin TTM -16.8 %
PE Ratio
Return On Assets TTM -0.68 %
PEG Ratio
Return On Equity TTM -2.65 %
Wall Street Target Price 71.73 USD
Revenue TTM 387 137 984 USD
Book Value 12.29 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 29.4 %
Dividend Yield
Gross Profit TTM 197 665 000 USD
Earnings per share -0.31 USD
Diluted Eps TTM -0.31 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY 844.8 %
Profit Margin -4.12 %

Dividend Analytics AXNX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AXNX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation AXNX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 156.25
Enterprise Value Revenue 8.5444
Price Sales TTM 9.4106
Enterprise Value EBITDA 402.6352
Price Book MRQ 5.4078

Financials AXNX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AXNX

For 52 weeks

47.59 USD 69.68 USD
50 Day MA 67.67 USD
Shares Short Prior Month 3 409 599
200 Day MA 62.1 USD
Short Ratio 3.74
Shares Short 3 591 370
Short Percent 7.54 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

430.16 USD Microsoft Corporation +3.16 (+0.74%)
Detailed analytics

ETF funds


S

SX7EEX

14.70 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) +0.1 (+0.64%)
Detailed analytics

Metals


Gold

2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics